Article info

Extended report
Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24

Authors

  1. Correspondence to Dr David Saadoun and Patrice Cacoub, Department of Internal Medicine, Service de Médecine Interne, AP-HP, Hôpital Pitié-Salpêtrière, Paris F-75013 France; david.saadoun{at}psl.aphp.fr or patrice.cacoub{at}psl.aphp.fr
View Full Text

Citation

Saadoun D, Resche Rigon M, Thibault V, et al
Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24

Publication history

  • Accepted February 24, 2013
  • First published April 20, 2013.
Online issue publication 
April 04, 2014

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.